Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00731237 · ClinicalTrials.gov registry record
XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in Delivery
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 2,517
- Enrollment target
NCT00731237 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 2,517 participants.
The verdict
NCT00731237 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 2,517 participants
- Enrollment target
Study Summary
This trial is to assess physician-determined XIENCE V® EECSS acute performance, deliverability and resource utilization in the catheterization lab during commercial use by various physicians with a range of coronary stenting experience
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,517 participants |
| Start Date | 2008-10 |
| Est. Completion | 2009-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00731237
The ClinicalTrials.gov registry entry for NCT00731237 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,517 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00731237 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00731237 about?
NCT00731237 is a clinical study titled "XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in Delivery". This trial is to assess physician-determined XIENCE V® EECSS acute performance, deliverability and resource utilization in the catheterization lab during commercial use by various physicians with a range of coronary stenting experience
What is the current status of trial NCT00731237?
This trial is currently completed. The enrollment target is 2,517 participants. The study started on 2008-10. Estimated completion is 2009-10.
Who is sponsoring clinical trial NCT00731237?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.